FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

29373211000001103: Lecicarbon C suppositories (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Apr 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
91400301000001115 Lecicarbon C suppositories (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
91400401000001111 Lecicarbon C suppositories (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lecicarbon C suppositories (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) Is a Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) Has active ingredient Monobasic sodium phosphate true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) Has active ingredient Sodium bicarbonate true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) Has specific active ingredient Sodium bicarbonate true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) Has specific active ingredient Sodium dihydrogen phosphate anhydrous true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) Has dispensed dose form Suppository true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) Is a Lecicarbon C true Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) Has manufactured dose form Suppository false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lecicarbon C suppositories (Aspire Pharma Ltd) 10 suppository 2 x 5 suppositories Has AMP True Lecicarbon C suppositories (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start